---

$2.13

-0.0550 ( -2.52% ) 1.2M

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-14	Sale	-3107.00	Silver Ronald
2024-08-14	Sale	-9910.00	John Minardo
2024-06-21	Sale	-24311.00	Dreyfus Andrew
2024-06-21	Sale	-24311.00	DENNER ALEXANDER J
2024-06-21	Sale	-24311.00	Moukheibir Catherine
2024-06-21	Sale	-24311.00	Shepard Jay
2024-06-21	Sale	-24311.00	McHugh Julie
2024-06-21	Sale	-24311.00	Kessler Marla L
2024-06-21	Sale	-24311.00	Duane Jon R
2024-06-21	Sale	-24311.00	Currie Mark G

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.